Yanira Méndez

Yanira Méndez

Auto-generated profile, based on publicly available information

Yanira Méndez

Department of Bioorganic Chemistry Leibniz Institute of Plant Biochemistry Weinberg 3 6120 Halle Saale) Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2018 in Accounts of Chemical Research
Verified
Journal Article
Closed access
LRLeslie Reguera
Leslie Reguera
YMYanira Méndez
Yanira Méndez
AHAna R. Humpierre
Ana R. Humpierre
OVOscar Valdés
Oscar Valdés
DRDaniel G. Rivera
Daniel G. Rivera

4 July 2021 in ACS Chemical Biology
Verified
Journal Article
Closed access
YVYury Valdes-Balbin
Yury Valdes-Balbin
DSDarielys Santana-Mederos
Darielys Santana-Mederos
LQLauren Quintero
Lauren Quintero
SFSonsire Fernández
Sonsire Fernández
LRLaura Rodriguez
Laura Rodriguez
VBVicente Verez Bencomo
Vicente Verez Bencomo

21 December 2018 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
AVAldrin Vasco Vidal
Aldrin Vasco Vidal
YMYanira Méndez
Yanira Méndez
APAndrea Porzel
Andrea Porzel
JBJochen Balbach
Jochen Balbach
LWLudger A. Wessjohann
Ludger A. Wessjohann
DRDaniel G. Rivera
Daniel G. Rivera

19 January 2018 in Chemical Science
Verified
Journal Article
Open access
PDF file
YMYanira Méndez
Yanira Méndez
JCJanoi Chang
Janoi Chang
AHAna R. Humpierre
Ana R. Humpierre
AZAbel Zanuy
Abel Zanuy
RGRaine Garrido
Raine Garrido
DRDaniel G. Rivera
Daniel G. Rivera
A new synthetic strategy for the development of multivalent antibacterial glycoconjugate vaccines is described. The approach comprises the utilization of an isocyanide-based multicomponent process for the conjugation of functionalized capsular polysaccharides of S. pneumoniae and S. Typhi to carrier proteins such as diphtheria and tetanus toxoids. For the first time, oxo- and carboxylic acid-functionalized polysaccharides could be either independently or simultaneously conjugated to immunogenic proteins by means of the Ugi-multicomponent reaction, thus leading to mono- or multivalent unimolecular glycoconjugates as vaccine candidates. Despite the high molecular weight of the two or three reacting biomolecules, the multicomponent bioconjugation proved highly efficient and reproducible. The Ugi-derived glycoconjugates showed notable antigenicity and elicited good titers of functional specific antibodies. To our knowledge, this is the only bioconjugation method that enables the incorporation of two different polysaccharidic antigens to a carrier protein in a single step. Applications in the field of self-adjuvanting, eventually anticancer, multicomponent vaccines are foreseeable.

1 February 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YMYanira Méndez
Yanira Méndez
GAGerman De Armas
German De Armas
IPIdalia Pérez
Idalia Pérez
TRTamara Rojas
Tamara Rojas
MVMario S. Valdés-Tresanco
Mario S. Valdés-Tresanco
DRDaniel G. Rivera
Daniel G. Rivera

18 August 2020 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
AHAna R Humpierre
Ana R Humpierre
AZAbel Zanuy
Abel Zanuy
MSMirelys Saenz
Mirelys Saenz
RGRaine Garrido
Raine Garrido
AVAldrin Vasco Vidal
Aldrin Vasco Vidal
DRDaniel G Rivera
Daniel G Rivera